Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/economie/novel-psychoactive-substances/descriptif_3895604
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3895604

Novel Psychoactive Substances, Softcover reprint of the original 1st ed. 2017 Policy, Economics and Drug Regulation

Langue : Anglais

Coordonnateurs : Corazza Ornella, Roman-Urrestarazu Andres

Couverture de l’ouvrage Novel Psychoactive Substances

In light of the recent emergence of Novel Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it. It presents the first comprehensive overview of the international regulation, policy and market structure of the NPS phenomenon, offering a guide to inform legislative discussions and demonstrating from a comparative perspective the different approaches used to address the rise of NPS to date. It covers topics such as organized crime, drug markets, clinical evidence on NPS, and different regulatory approaches also in less explored settings such as prisons and sport environments.

Overall, this highly informative and well-structured repository of different experiences with NPS policy, law and regulation offers an essential primary source of evidence for anyone interested in the area of drug and NPS policy, health economics and p

ublic health.

1.The Global Emergence of NPS: An Analysis of a New Drug Trend.- 2.Legislating NPS in the European Union.- 3.Regulation as Global Drug Governance – How New is the NPS Phenomenon?.- 4.Anti-Doping Challenges with Novel Psychoactive Substances in Sport.- 5.Exploring Novel Policy Responses to NPS and ‘legal highs’ in New Zealand, Poland, Republic of Ireland and the United Kingdom.- 6.Regulating NPS in the Middle East: A Critical Juncture.- 7.Finding Novel Policy Response to the Challenge of NPS in Kazakhstan: Reconsidering Existing Policy and the Work of Health Professionals.- 8.NPS Policy Pitfalls: The Implementation and Management Challenges Within the Prison, Police and Health Services in the United Kingdom.- 9.NPS: An Opportunity to Move From Blanket Prohibition to a More Functionalist Approach?.- 10.The Challenges in Interpreting National-Level Strategic Indicators: A Drug Enforcement Administration Analyst’s Perspective.- 11.Harmonizing NPS Legislation Across the European Union: An Utopia?.- 12.New psychoactive substances: The Regulatory Experience and Assessment of Options.

Dr. Ornella Corazza is a Reader in Substance Addictions and Behaviours at University of Hertfordshire and leading expert in the field of Novel Psychoactive Substances (NPS). She has published numerous papers in the field and her work has been recognized and prized internationally, including with the 2013 European Health Award. She has previously held Fellowships at the University of Padua (Italy), University of Bochum (Germany), University of London (SOAS; King’s College) and at the Centre of Excellence on Death and Life Studies at the University of Tokyo (Japan). She is also a Visiting Professor at Sapienza University of Rome. As a consequence of working internationally in different academic environments, she has developed a unique specialism in the combined fields of health, culture and legislation. In total, Dr Corazza is author of over 200 journal articles, book chapters and conference papers. They cover the main classes of NPS as well new methods for the rapid identification of novel drug trends, prevention and policy recommendations.

Dr Andres Roman-Urrestarazu combined expertise in psychiatry, mental health and health economics allowed him to make original contributions in the fields of substance abuse where he has developed a growing body of research in the field of NPS Policy. He is Assistant Professor at Maastricht University Department of International Health and concurrently holds the Gilling’s Fellowship in Global Public Health at the Institute of Public Health (IPH), University of Cambridge and the Institut Louis Pasteur (ILP) Paris. He currently co-supervises PhD students at the IPH in Cambridge and Maastricht University Department of International Health where he leads a project that studies the association between austerity, macroeconomic indicators and substance misuse. Concurrently with this policy agenda, his clinical work and research is based in the Autism Research Centre, Department of Psychiatry, University of C

Provides a timely analysis of the social and economic impact of the NPS phenomenon Presents the first comprehensive overview of the international regulation, policy and market structure of the NPS phenomenon Covers topics such as organized crime, drug markets, clinical evidence on NPS, and different regulatory approaches

Date de parution :

Ouvrage de 178 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

94,94 €

Ajouter au panier

Date de parution :

Ouvrage de 178 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

Prix indicatif 94,94 €

Ajouter au panier